Table 4.
Serum lipid profile in C, HFD, HFD + E and HFD + Stn treated groups
| Group | TG (mg/dl) | TC (mg/dl) | HDL-C (mg/dl) | LDL-C (mg/dl) | VLDL-C (mg/dl) | AI |
|---|---|---|---|---|---|---|
| C | 61 ± 3.6 | 76 ± 2.1 | 29.8 ± 2.9 | 41 ± 1.4 | 12.2 ± 0.7 | 1.98 ± 0.18 |
| HFD | 93 ± 4.6a | 124 ± 6.4a | 21.5 ± 0.6a | 89 ± 3.5a | 18.7 ± 0.93a | 4.8 ± 0.2a |
| HFD + E | 59.3 ± 1.4b | 72.2 ± 1b | 28.1 ± 2.2b | 39 ± 1.1b | 11.8 ± 0.3b | 2 ± 0.26b |
| HFD + Stn | 58 ± 2.6b | 78 ± 4.9b | 29 ± 2.4b | 40 ± 1.5b | 11.5 ± 0.5b | 2.1 ± 0.22b |
Results are expressed as mean ± SE. ap<0.05: Significantly different from control group. bp<0.05: Significantly different from HFD treated group. TG, triglycerides; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; VLDL-C, very low density lipoprotein cholesterol; AI, atherogenic index.